web counter

First Phase 3 trial data for MDMA therapy sets path for approval

A patient undergoing MDMA treatment in one of the Phase 2 clinical trials

The first results from Phase 3 trials testing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) have been announced. The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving the way for a landmark US Food and Drug Administration (FDA) approval in 2023.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , ,